CLOs on the Move

Neuronetics

www.neurostar.com

 
Neuronetics, Inc. believes that mental health is as important as physical health. As a global leader in neuroscience, Neuronetics is redefining patient and physician expectations with its NeuroStar Advanced Therapy for Mental Health. NeuroStar is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions when traditional medication hasn`t helped. NeuroStar is FDA-cleared for adults with major depressive disorder (MDD), as an adjunct for adults with obsessive-compulsive disorder (OCD), and to decrease anxiety symptoms in adult patients with MDD that may exhibit comorbid anxiety symptoms (anxious depression). NeuroStar Advanced Therapy is the leading ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Andrew Macan
 Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary Profile

Similar Companies

Z-Sciences Corp

Z-Sciences Corp is a Westmount, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Twin Med

Twin Med is a Santa Fe Springs, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dilon Diagnostics

Dilon Diagnostics is a Newport News, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hymed Group

Hymed Group Corp. is a Bethlehem, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Novadaq

Enabling surgeons with clinically-relevant, innovative fluorescence imaging solutions to enhance the lives of patients and their surgeons, while reducing health care costs, is Novadaq’s global mission. SPY fluorescence imaging technology provides surgeons with real-time visualization, leading to improved outcomes and reduced costs without exposing the patient to harmful ionizing radiation or contrast dye toxicity. More than 130 peer-reviewed publications demonstrate that the use of SPY during complex surgery, leads to fewer post-operative complications and lower hospital costs. The SPY Imaging System is United States Food and Drug Administration (“FDA”) 510(k) cleared for use in seven surgical specialties. The endoscopic version of SPY called PINPOINT®, combines the capabilities of SPY Imaging with high definition (“HD”) visible light visualization offered by conventional endoscopes. Our unique business model of partnering with market-leading companies to drive adoption of our fluorescence imaging technology, while building our own commercial infrastructure is the cornerstone of our corporate strategy for growth.